Gene Query: GRIPAP1

Dataset Description Geneva Score
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 63.52
Genome wide expression change in LCC2 and MCF-7 cells 26.01
Effect of Hotair overexpression in human breast cancer cell lines 21.75
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 21.75
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 21.55
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 21.55
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 19.49
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 18.57
IDH3a KO RNA-seq 16.04
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 15.28
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 14.99
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 14.96
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 13.97
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 13.79
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 13.79
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 12.81
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 12.68
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 11.96
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 11.9
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 11.9
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 11.7
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 11.7
Control of prostate tumour growth by the long non-coding RNA GHSROS 11.69
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 11.61
The regulartory role of ZCCHC24 in splicing machinery 11.54
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 11.45
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 11.37
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 11.37
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 11.24
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 11.19
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 11.15
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 10.82
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 10.72
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 10.65
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 10.57
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 10.57
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 10.51
Paxillin regulates genomic networks in prostate cancer [PC3] 10.45
Transcriptional effect of ETV1 knockdown in melanoma cells 10.18
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 10.15
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 9.94
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 9.91
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 9.82
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 9.82
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 9.55
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 9.36
The landscape of alternative splicing in aggressive prostate cancers 9.25
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 9.09
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 9.07
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 9.07
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 9.07
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 8.97
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 8.95
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 8.84
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 8.62
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 8.5
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 8.48
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 8.13
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 8.04
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 7.96
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 7.9
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 7.86
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 7.86
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 7.84
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 7.8
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 7.73
miR941 overexpression experiment 7.64
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 7.61
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 7.59
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 7.48
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 7.48
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 7.47
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 7.43
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 7.36
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 7.33
High-throughput sequencing of pluripotent cells 7.3
U2AF1 mutations alter splice site recognition in hematological malignancies 7.28
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 7.27
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 7.24
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 7.21
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 7.16
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 7.11
Silencing SPIB in attached and floating state of H1703 lung cancer cells 7.07
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 7.04
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 7.02
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 7.02
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 7.02
Transcriptional profiling of LS1034 cells treated with tepoxalin 7.0
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.93
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.93
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 6.93
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 6.8
Loss of CREBBP results in gene expression repression in lymphoma cells 6.8
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 6.78
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 6.78
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 6.63
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 6.63
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 6.59
Human cells contain natural double-stranded RNAs with potential regulatory capacity 6.58
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 6.54
RNA-seq of tumor cells following angiopellosis extravasation 6.53
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 6.46
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 6.44
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 6.43
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 6.41
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 6.41
Identification of Sin3B regulated genes during quiescence 6.37
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 6.37
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 6.36
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 6.31
6.31
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 6.27
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 6.27
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 6.14
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 6.14
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 6.13
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 6.11
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 6.01
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 5.98
Gene expression profiling of leukemia cells following asparagine depletion 5.9
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 5.89
RNA-seq analysis of AML cells in response to ASLAN003 5.87
Landscape and variation of RNA secondary structure across the human transcriptome 5.86
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 5.81
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 5.79
A transcriptome-wide divergence in protein translation scales with LIN28B expression 5.79
circRNA-sequencing 5.76
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 5.75
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 5.67
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 5.66
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 5.65
quanTIseq: quantifying immune contexture of human tumors 5.63
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 5.61
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 5.59
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 5.59
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 5.51
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 5.51
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 5.51
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 5.48
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 5.45
MYCi361 regulates MYC target genes 5.42
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 5.38
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 5.32
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 5.31
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 5.31
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 5.28
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 5.28
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 5.27
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 5.25
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 5.2
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 5.19
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 5.19
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 5.18
In situ CAPTURE of chromatin interactions by biotinylated dCas9 5.18
Transcriptomic analysis of the HOTAIR-regulated genes 5.17
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 5.15
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 5.14
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 5.14
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 5.14
Accurate annotation of human protein-coding small open reading frames 5.12
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 5.04
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 5.04
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 5.02
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 5.0
Effects of rFVIIIFc on human macrophages 4.97
Searching for target genes of miR-508/509/506/514 in HCT116 cells 4.94
Intrahepatic MAIT cell gene expression revealed by RNA-seq 4.94
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 4.91
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 4.89
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 4.87
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 4.8
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 4.79
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 4.79
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 4.76
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 4.76
METTL3 promotes translation in human cancer cells 4.76
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 4.74
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 4.74
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 4.7
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 4.69
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 4.68
Transcription elongation regulates genome 3D structure 4.67
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 4.66
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 4.61
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 4.59
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 4.59
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 4.59
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 4.59
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 4.58
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 4.58
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 4.57
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 4.57
Identification of Nrf2 regulated genes by RNA sequencing 4.55
Nrf2 regulated genes in A549 cells 4.55
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 4.54
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 4.5
Global analyses of the effect of different cellular contexts on microRNA targeting 4.5
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 4.48
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 4.48
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.48
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 4.47
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.46
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 4.45
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 4.45
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 4.45
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 4.45
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 4.45
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 4.4
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 4.39
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 4.38
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 4.38
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 4.36
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 4.36
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 4.31
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 4.31
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 4.28
ENCODE Cold Spring Harbor Labs Long RNA-seq 4.27
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 4.27
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.25
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 4.21
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 4.2
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 4.19
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 4.17
Illumina Total RNA-seq in HeLa 4.17
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 4.17
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 4.16
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 4.13
IMP3 regulated gene expression in breast cancer cells 4.12
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 4.12
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 4.09
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 4.09
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 4.07
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 4.06
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 4.01
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 4.01
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 3.98
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 3.98
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 3.97
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 3.96
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 3.96
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 3.94
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 3.93
Differential gene expression profiles in imatinib-resistant cell lines 3.92
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 3.91
Expression data from miR340 overexpressing human A549 cells 3.89
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 3.86
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 3.85
Total RNA sequencing of APC mutant and wt colonic organoids 3.84
The effect of Abl kinases on non-small cell carcinoma global transcriptome 3.84
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 3.78
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 3.76
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 3.76
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.75
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 3.75
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 3.73
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 3.73
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.69
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 3.65
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.64
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 3.6
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 3.6
Human embryonic stem cells in E8 and AKIT culture medium 3.58
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 3.58
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 3.56
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 3.56
X-Ray induced DNA-Hydroxymethylation changes 3.54
Gene expression analysis upon mtDNA depletion [RNA-seq] 3.52
Gene expression analysis upon mtDNA depletion 3.52
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 3.5
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 3.5
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 3.5
RNA-seq of naive and primed ES cells (NHSM) 3.49
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.45
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 3.44
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 3.39
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 3.39
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.38
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.38
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 3.38
mRNA recovered upon RNF219 IP. [RNA-IP] 3.35
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 3.35
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.35
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.35
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 3.32
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 3.31
Transcriptome analysis of peripheral blood monocytes 3.31
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 3.29
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.29
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.28
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 3.27
RNAseq Study in CC-671 Treated Cal-51 Cells 3.26
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 3.21
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 3.21
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 3.19
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 3.16
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 3.16
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 3.14
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 3.14
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.14
RNA seq with AML (NB4) cells upon FTO inhibition 3.1
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.06
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 3.04
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 3.0
A map of gene expression in neutrophil-like cell lines 2.99
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 2.99
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.98
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 2.97
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 2.93
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 2.91
Transcription control by the ENL YEATS domain in acute leukemia 2.91
Characterization of parental and rociletinib-resistant derived H1975 cell lines 2.91
Ribosomal protein RPL26 is the principal target of UFMylation 2.89
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 2.89
An integrative analysis of non-coding regulatory DNA variations associated with autism 2.87
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 2.86
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 2.83
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.81
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 2.78
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.77
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 2.77
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.77
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 2.76
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.75
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.7
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 2.69
Gene expression in GBM with Cav3.2 inhibition 2.69
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 2.66
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 2.66
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 2.65
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.64
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 2.61
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 2.61
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 2.59
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 2.56
RNA-seq differential expression studies: more sequence, or more replication? 2.55
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 2.52
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.49
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 2.49
Microglia innatly develop within cerebral organoids 2.49
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 2.48
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 2.41
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 2.4
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 2.36
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 2.36
Co-regulation of splicing by Rbfox1 and hnRNP M 2.36
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 2.34
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.3
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 2.3
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 2.28
Hepatitis C virus functionally sequesters miR-122 2.28
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 2.27
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 2.26
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 2.23
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 2.23
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 2.23
Subtle asymmetry of gene expression in embryonic and foetal human brains 2.23
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.22
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 2.17
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 2.14
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 2.14
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 2.14
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.12
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 2.07
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 2.03
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 2.03
Role of FGFR1 in neuronal devlopment 2.03
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.98
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.98
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.97
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 1.96
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.9
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 1.85
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.82
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.82
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.82
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.82
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.81
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.79
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.76
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 1.75
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.69
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.69
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.68
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.66
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 1.61
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.59
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.58
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.58
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.58
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 1.56
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.53
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.53
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 1.5
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.46
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.46
Repurposing of promoters and enhancers during mammalian evolution 1.44
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 1.43
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.36
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 1.36
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 1.36
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.35
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 1.3
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 1.29
The pioneer factor CEBPA modulates vitamin D signaling 1.29
Derivation and differentiation of haploid human embryonic stem cells 1.21
Energy Metabolism during Anchorage-Independence 1.19
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 1.19
BACH2 in human plasma cell fate decision 1.19
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.17
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 1.17
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.15
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 1.14
Human ovarian granulosa cell transcriptome 1.12
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.11
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 1.07
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 1.07
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.04
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 1.02
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.01
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 1.01
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.0
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.98
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 0.98
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.94
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 0.94
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.92
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.87
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 0.81
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.81
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.8
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.76
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.74
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.72
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 0.72
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.72
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.72
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.69
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.67
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.67
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.65
iPSC derived motor neuron cultures from C9ORF72 carriers 0.64
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.63
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.62
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.62
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 0.59
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.56
RNA-Seq from human ILC transitional populations 0.56
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.56
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.56
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.53
The role of m6A/m-RNA methylation in stress response regulation 0.53
Epigenomic conservation of transposable element silencing 0.5
Epigenomic conservation of transposable element silencing [RNA-seq] 0.5
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.47
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.46
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.46
Glioblastoma stem cells infected by ZIKA virus 0.46
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 0.45
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.44
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.44
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.43
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.41
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.39
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.38
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.38
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.38
The bromodomain protein BRD4 regulates splicing during heat shock 0.36
naive T cell heterogeneity after neonatal thymectomy 0.33
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.33
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.32
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.31
mRNA expression profile of Lymphocytes by high-throuput sequencing 0.31
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.31
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.31
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.28
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.28
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.24
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.23
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.23
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 0.23
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.19
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.17
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.17
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.15
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.1
Function and hormonal regulation of GATA3 in human first trimester placentation 0.1
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.09
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.08
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.08
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.07
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.07
MHC Transcriptomic landscape at haplotype-specific resolution 0.07
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 0.07
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.05
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.05
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.05
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 0.04
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.03
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.01
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation